Study from @Yale looking at the association between the #Pfizer#COVID19#vaccine and #SARSCoV2 positivity among 542 adolescents when the Delta variant of SARS-CoV-2 was predominant and within 4 months of the vaccine rollout for adolescents showed:
-estimated effectiveness of the #pfizer vaccine was 91%, with 93% protection against symptomatic infections & 85% effectiveness against asymptomatic infection
Conclusion: These findings suggest that the #Pfizer#vaccine was effective in adolescents within 4 months of #immunization, including against infections caused by the #Delta#variant.
Thank you to our Keynote Speakers from COAST-to-COAST for their insightful presentations & to the 8,752 participants who attended @MedNewsWeek Conference in February 2022. It was a pleasure learning from everyone.
Study looking at the impact of vaccine misinformation found:
-66% of U.S. adults say they would be likely to recommend vaccinating a hypothetical 5-11 yr olds in their household who is eligible for the #Covid19#vaccine.
-39% of the vaccinated-but-not-boosted hold high levels of misinformation about the effects and safety of #vaccines
-the more that unvaccinated adults worry about getting #long#Covid, the more likely they are to say they will get vaccinated
-40% of the #unvaccinated – or 9% of the total survey sample – are potentially persuadable to be #vaccinated
-long-term partial reprogramming led to rejuvenating effects in different tissues, such as the #kidney & #skin, and at the #organismal level; duration of the treatment determined the extent of the beneficial effects.
A discussion about Gastroenterology & the latest developments chronic diarrheal syndrome from one of GI’s global leaders-- Dr. Paul Feuerstadt from @Yale (@DrPaulGastro)
A discussion about Gastroenterology & the latest developments chronic diarrheal syndrome from one of GI’s global leaders-- Dr. Paul Feuerstadt from @Yale (@DrPaulGastro)
MedNews Week Conference - Infectious Disease & Gastroenterology - Dr. Paul Feuerstadt (Yale) twitter.com/i/broadcasts/1…
Happening now!
A discussion about Gastroenterology & the latest developments chronic diarrheal syndrome from one of GI’s global leaders-- Dr. Paul Feuerstadt from @Yale (@DrPaulGastro)